| payload |
{"created_at":"2026-04-08T02:28:02.401 {"created_at":"2026-04-08T02:28:02.401723+00:00","dedupe_key":"signal_enriched:discovery_sec_filing_delta:f56810690a54e02d","evidence_event_ids":["evt_628de71a3694"],"signal_type":"discovery_sec_filing_delta","source":"discovery_sec_filings","value":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","as_of":"2026-04-08T02:28:02.401723+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","company":"Zymeworks Inc.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","article_chars":2303,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d8c9f5d1d9202ea9","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","content_type":"text/plain","enriched_at":"2026-04-08T02:28:44.736828+00:00","extraction_method":"heuristic","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt","source_event_id":"evt_628de71a3694","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"4","fp":"759fffbef4aedfe4","kind":"sec_filing","published_at":"20260407","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-07","2026-04-06","2026-04-05","2026-04-05","2026-04-07","2022-07-12"],"entities":[{"asset_class":"equity","name":"Zymeworks Inc.","relevance":"high","symbol":"ZYME","type":"issuer"},{"asset_class":"person","name":"Kristin Stafford","relevance":"high","symbol":"","type":"reporting_person"},{"asset_class":"equity","name":"Common Stock","relevance":"high","symbol":"","type":"security"}],"event_type":"listing","information_gaps":["What specifically changed vs prior known state is not provided in the signal (no prior filing comparison content included).","The filing text excerpt includes vesting language for both RSUs and stock options, but the excerpt does not clearly map which vesting schedule applies to each of the three RSU quantities.","No transaction type (e.g., grant vs vest vs sale) is explicitly labeled in the provided excerpt beyond the presence of RSU entries and the vesting descriptions.","No total share count or net change is explicitly stated in the provided text."],"key_facts":["SEC accession number: 0001193125-26-145305.","Form type: 4 (ownership report).","Conformed period of report: 20260406; filed as of date: 20260407.","Reporting person: Kristin Stafford; role shown as EVP, Chief Financial Officer.","Security type shown as Common Stock.","The filing lists three RSU entries with quantities: 178000, 119000, and 50000 (each with price shown as 0.00 in the provided text).","The text states: \u201cEach restricted stock unit (\"RSU\") represents the contingent right to receive, upon vesting of the RSU, one share of the Issuer's common stock.\u201d","The text includes vesting language: \u201cRSUs vest in four equal annual installments beginning on first anniversary of grant date.\u201d","The text also includes vesting language: \u201cRSUs vest in three equal annual installments beginning on first anniversary of grant date.\u201d","The text includes additional vesting language for stock options: \u201cStock options vest as follows: (i) 25% of underlying shares of common stock on first anniversary of grant date and (ii) remainder of underlying shares of common stock in 36 equal monthly installments on last day of month following first anniversary of grant date.\u201d","Signature: /s/ Catherine Graham, Attorney-in-Fact; dated 2026-04-07."],"numeric_claims":[{"label":"RSU quantity (entry 1)","value":"178000"},{"label":"RSU quantity (entry 2)","value":"119000"},{"label":"RSU quantity (entry 3)","value":"50000"}],"primary_claim":"On 2026-04-07, Zymeworks Inc. filed Form 4 reporting Kristin Stafford\u2019s RSU-related transactions involving 178,000 shares, 119,000 shares, and 50,000 shares of common stock (with vesting described in the filing).","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Zymeworks Inc. filed a Form 4 on 2026-04-07 covering transactions by reporting person Kristin Stafford (EVP, Chief Financial Officer) related to restricted stock units (RSUs) and common stock. The filing includes grant/vesting details and indicates RSUs represent the contingent right to receive one share of common stock upon vesting.","topics":["SEC Form 4","insider transactions","restricted stock units (RSUs)","vesting schedule","Zymeworks Inc."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 4 \u00b7 Zymeworks Inc. \u00b7 Filed 20260407","ticker":"ZYME","tickers":["ZYME"],"title":"ZYME filed 4","url":"https://www.sec.gov/Archives/edgar/data/1937653/0001193125-26-145305.txt"}}... |